Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Thallion closes phase II TLN-232 trial following arbitral tribunal decision

June 18, 2010

OncoMed and Bayer Schering form anticancer stem cell alliance

June 18, 2010

Phase II trial of GDC-0449 in colorectal cancer does not meet primary endpoint

June 18, 2010

AZD-6244 is beneficial in phase II trial in IRPTC and PTC

June 18, 2010

Final phase II data on voreloxin/cytarabine in AML support phase III testing

June 18, 2010

Milatuzumab-doxorubicin conjugate enters phase I/II trial in MM

June 18, 2010

Novel DNA-alkylating agents described by Syntarga

June 18, 2010

EMA approves update to bortezomib label for multiple myeloma

June 17, 2010

Pieris begins phase I trial of anticalin PRS-050 in cancer

June 17, 2010

Galera to advance dismutase mimetics for prevention of oral mucositis

June 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...